Project Details
Description
A Randomized Open-label Phase 2 Study of TALazoparib with or without ENzaluTamide in Patients with Metastatic Castration-Resistant Prostate Cancer and HRR Mutations After Progression on Abiraterone Acetate (TALENT)
| Status | Active |
|---|---|
| Effective start/end date | 6/25/25 → 6/24/36 |
Funding
- PROSTATE CANCER CLINTRIAL CONSORTIUM LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.